SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-078170
Filing Date
2015-11-03
Accepted
2015-11-03 17:56:40
Documents
1
Period of Report
2015-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3717
  Complete submission text file 0001209191-15-078170.txt   5245
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O FIVE CORNERS CAPITAL 700 WEST GEORGIA STREET, SUITE 2500 VANCOUVER A1 V7Y 1B3
Business Address
Bridger Gary (Reporting) CIK: 0001600049 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 151194853